368
Participants
Start Date
October 31, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Fluzone® Intradermal Vaccine
A 0.1mL single-dose, in a latex-free, pre-filled microinjection system with an ultra-fine micro-needle. The active substance is prepared from influenza viruses propagated in embryonated chicken eggs. Fluzone® Intradermal is approved for use in persons 18 through 64 years of age and will be purchased from Sanofi Pasteur, Inc.
Fluzone® (Intramuscular) vaccine
A 0.5 mL single-dose delivered via syringe using single-dose vials. The active substance is prepared from influenza viruses propagated in embryonated chicken eggs. Fluzone® for intramuscular injection is approved for persons 6 months and older and will be purchased from Sanofi Pasteur, Inc.
University of Rochester Medical Center, Rochester
Northwestern University, Chicago
National Jewish Health, Denver
Oregon Health & Science University, Protland
Boston Children's Hospital, Boston
Atopic Dermatitis Research Network
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH